Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03896074 |
| Title | Atezolizumab Versus Atezolizumab Plus Bevacizumab as First Line in NSCLC Patients (BEAT) (BEAT) |
| Acronym | BEAT |
| Recruitment | Unknown status |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Fondazione Ricerca Traslazionale |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | ITA |
CKB BOOST